Cardiac Implantable Electronic Device Infections in Saudi Arabia: Incidence, Timing, Causative Organisms, and Outcomes - A Multicenter Study.

IF 1.4 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS
Journal of the Saudi Heart Association Pub Date : 2026-02-05 eCollection Date: 2025-01-01 DOI:10.37616/2212-5043.1468
Saad Albogami, Wael Alqarawi, Ahmed Alfagih, Hiatham Alenzi, Mohammad Alshehri, Mossab Aljuaid, Saeed Alqahtani, Norah Alswaidan, Mohammad Alharbi, Norah Alkaltham, Lama Alasmri, Rghd Sadkh, Muna Albashari, Nour Aljumaa, Imad Tleyjeh
{"title":"Cardiac Implantable Electronic Device Infections in Saudi Arabia: Incidence, Timing, Causative Organisms, and Outcomes - A Multicenter Study.","authors":"Saad Albogami, Wael Alqarawi, Ahmed Alfagih, Hiatham Alenzi, Mohammad Alshehri, Mossab Aljuaid, Saeed Alqahtani, Norah Alswaidan, Mohammad Alharbi, Norah Alkaltham, Lama Alasmri, Rghd Sadkh, Muna Albashari, Nour Aljumaa, Imad Tleyjeh","doi":"10.37616/2212-5043.1468","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Cardiac implantable electronic devices (CIEDs) substantially improve outcomes in cardiac patients, but device-related infection can negate these benefits. Data on the epidemiology of CIED infections in Saudi Arabia are limited.</p><p><strong>Methods: </strong>We performed a multicenter retrospective cohort study of consecutive patients receiving CIEDs (pacemakers [PPM], implantable cardioverter-defibrillators [ICD], and cardiac resynchronization devices [CRT]) at three tertiary hospitals in Riyadh, Saudi Arabia, from January 2017 through December 2021. Patients were followed for at least one year post-implantation. Data collected included patient demographics, device type (new implant, replacement, revision), infection timing and microbiology, management (device extraction vs conservative treatment), and outcomes.</p><p><strong>Results: </strong>Of 4080 CIED recipients, 114 (2.8 %) developed device infections (incidence 98.8 per 10,000 person-years). CRT-P (cardiac resynchronization therapy pacemaker) devices had the highest infection rate (7.7 %). Revision procedures carried higher infection rates than initial implants or generator replacements (10.0 % vs 2.1 % vs 2.7 %; P < 0.001). The most common pathogens were <i>Staphylococcus aureus</i> (30.1 %), coagulase-negative staphylococci (10.6 %), and <i>Pseudomonas aeruginosa</i> (8.8 %); 38.9 % of infections were culture-negative. Systemic infections and patients managed without device removal had significantly higher mortality (32.3 % vs 8.2 % for systemic vs pocket; 48.4 % vs 12.0 % for no extraction vs extraction; P < 0.001 for both).</p><p><strong>Conclusions: </strong>In this large Saudi cohort, CIED infection occurred in 2.8 % of patients, particularly following revision procedures and in CRT-P recipients. Infections were often culture-negative and associated with substantial mortality, especially in systemic cases or when devices were not removed. These findings highlight the importance of strict infection-prevention protocols, early recognition, and prompt complete device extraction to improve patient outcomes.</p>","PeriodicalId":17319,"journal":{"name":"Journal of the Saudi Heart Association","volume":"37 4","pages":"20"},"PeriodicalIF":1.4000,"publicationDate":"2026-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12948620/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Saudi Heart Association","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37616/2212-5043.1468","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Cardiac implantable electronic devices (CIEDs) substantially improve outcomes in cardiac patients, but device-related infection can negate these benefits. Data on the epidemiology of CIED infections in Saudi Arabia are limited.

Methods: We performed a multicenter retrospective cohort study of consecutive patients receiving CIEDs (pacemakers [PPM], implantable cardioverter-defibrillators [ICD], and cardiac resynchronization devices [CRT]) at three tertiary hospitals in Riyadh, Saudi Arabia, from January 2017 through December 2021. Patients were followed for at least one year post-implantation. Data collected included patient demographics, device type (new implant, replacement, revision), infection timing and microbiology, management (device extraction vs conservative treatment), and outcomes.

Results: Of 4080 CIED recipients, 114 (2.8 %) developed device infections (incidence 98.8 per 10,000 person-years). CRT-P (cardiac resynchronization therapy pacemaker) devices had the highest infection rate (7.7 %). Revision procedures carried higher infection rates than initial implants or generator replacements (10.0 % vs 2.1 % vs 2.7 %; P < 0.001). The most common pathogens were Staphylococcus aureus (30.1 %), coagulase-negative staphylococci (10.6 %), and Pseudomonas aeruginosa (8.8 %); 38.9 % of infections were culture-negative. Systemic infections and patients managed without device removal had significantly higher mortality (32.3 % vs 8.2 % for systemic vs pocket; 48.4 % vs 12.0 % for no extraction vs extraction; P < 0.001 for both).

Conclusions: In this large Saudi cohort, CIED infection occurred in 2.8 % of patients, particularly following revision procedures and in CRT-P recipients. Infections were often culture-negative and associated with substantial mortality, especially in systemic cases or when devices were not removed. These findings highlight the importance of strict infection-prevention protocols, early recognition, and prompt complete device extraction to improve patient outcomes.

沙特阿拉伯心脏植入式电子设备感染:发病率、时间、致病生物和结果——一项多中心研究。
背景:心脏植入式电子装置(CIEDs)大大改善了心脏病患者的预后,但与装置相关的感染会抵消这些益处。沙特阿拉伯CIED感染的流行病学数据有限。方法:我们对2017年1月至2021年12月在沙特阿拉伯利雅得的三家三级医院连续接受cied(起搏器[PPM]、植入式心律转复除颤器[ICD]和心脏再同步装置[CRT])的患者进行了一项多中心回顾性队列研究。患者在植入后至少随访一年。收集的数据包括患者人口统计、器械类型(新植入物、置换、翻修)、感染时间和微生物学、管理(器械拔出vs保守治疗)和结果。结果:在4080名CIED受者中,114人(2.8%)发生器械感染(发病率为98.8 / 10000人年)。CRT-P(心脏再同步化治疗起搏器)装置的感染率最高(7.7%)。翻修手术的感染率高于初始植入物或发生器更换(10.0% vs 2.1% vs 2.7%; P < 0.001)。最常见的病原菌为金黄色葡萄球菌(30.1%)、凝固酶阴性葡萄球菌(10.6%)和铜绿假单胞菌(8.8%);38.9%的感染者培养阴性。全身性感染和未取出装置的患者死亡率明显更高(全身组32.3% vs袋式组8.2%;无拔牙组48.4% vs 12.0%;两者的P < 0.001)。结论:在这个庞大的沙特队列中,2.8%的患者发生了CIED感染,特别是在翻修手术后和CRT-P接受者中。感染通常为培养阴性,并与大量死亡率相关,特别是在全身性病例或未移除装置时。这些发现强调了严格的感染预防方案、早期识别和及时取出完整装置对改善患者预后的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of the Saudi Heart Association
Journal of the Saudi Heart Association CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
1.40
自引率
0.00%
发文量
30
审稿时长
15 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书